PursueCare

PursueCare

Virtual addiction treatment platform with MAT

Overview

PursueCare delivers telehealth addiction recovery and mental health services through a virtual clinic accessed via a mobile app. Patients work with a multidisciplinary team—including addiction medicine physicians, psychiatrists, counselors, therapists, and a pharmacist—for Medication-Assisted Treatment, therapy, psychiatric care for dual diagnoses, and at-home lab testing. It stands out through PursueCareRx, its in-house Joint Commission-accredited pharmacy that enables discreet home delivery of prescribed medications, plus access to FDA-authorized digital therapeutics reSET and reSET-O acquired in 2023, and it pursues in-network partnerships with health systems, employers, and plans to integrate care across settings. The goal is to remove barriers to treatment for underserved and remote communities by delivering private, comprehensive care that fits within the broader healthcare system.

About PursueCare

Simplify's Rating
Why PursueCare is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

Healthcare

Company Size

51-200

Company Stage

Series B

Total Funding

$31M

Headquarters

Middletown, Connecticut

Founded

2019

Simplify Jobs

Simplify's Take

What believers are saying

  • ASAM Conference presentation April 24-27 showcases digital therapeutics to addiction medicine specialists and enterprise partners.
  • Linda Kniebel's appointment as Head of Enterprise Partnerships accelerates health system and hospital integration expansion.
  • Ascend Labs referral program creates pharmaceutical brand partnerships increasing medication adherence and pharmacy revenue streams.

What critics are saying

  • Pear Therapeutics bankruptcy voids reSET and reSET-O acquisition, eliminating FDA-authorized digital therapeutics core offering.
  • State telehealth parity laws expiring post-COVID restrict reimbursement for app-based MAT and pharmacy delivery in key markets.
  • Joint Commission pharmacy audit failure risks PursueCareRx shutdown from non-compliance in home-delivery protocols.

What makes PursueCare unique

  • In-house Joint Commission-accredited pharmacy enables discreet home delivery of buprenorphine and MAT medications.
  • FDA-authorized digital therapeutics reSET and reSET-O provide app-based cognitive behavioral therapy integrated into platform.
  • Multidisciplinary care team includes addiction medicine providers, psychiatrists, counselors, therapists, and pharmacists in single virtual clinic.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$31M

Below

Industry Average

Funded Over

3 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Below Average

Industry standards

$35M
$30M
Patreon
$45M
Linktree
$65M
Substack
$100M
ClickUp

Benefits

Health Insurance

Remote Work Options

Paid Vacation

Growth & Insights and Company News

Headcount

6 month growth

-3%

1 year growth

-1%

2 year growth

1%
PursueCare
Sep 30th, 2025
PursueCare Welcomes Linda Kniebel, Our New Head of Enterprise Partnerships

PursueCare LLC is excited to announce that Linda Kniebel has joined PursueCare as its new Head of Enterprise Partnerships.

PursueCare
Apr 23rd, 2025
PursueCare to Spotlight Next-Gen Digital Therapeutics at the 56th American Society of Addiction Medicine (ASAM) Conference in Denver April 24-27

PursueCare to spotlight next-gen digital therapeutics at the 56th American Society of Addiction Medicine (ASAM) Conference in Denver April 24-27.

PursueCare
Oct 22nd, 2024
PursueCare Recognized as "Rising Star" in Mental and Behavioral Health at the Digital Health Hub Awards, Presented @HLTH Conference 2024

PursueCare recently introduced RESET(R) and RESET-O(R), the only FDA-authorized digital therapeutics for substance use disorder (SUD) and opioid use disorder (OUD).

PursueCare
Sep 3rd, 2024
PursueCare Recognized As Quarterfinalist in Health Hub Digital Health Awards

PursueCare is proud to announce that PursueCare LLC has been recognized as a quarterfinalist in the Health Hub Awards, Mental and Behavioral Health Rising Stars category:

Healthcare IT Today
Jan 5th, 2024
PursueCare Completes Series B Fundraising Round and Acquires Digital Therapeutics Developed by Pear Therapeutics, Inc.

PursueCare completes Series B fundraising round and acquires Digital Therapeutics developed by Pear Therapeutics, Inc.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for PursueCare right now.

Find jobs on Simplify and start your career today

We update PursueCare's jobs every few hours, so check again soon! Browse all jobs →